文献速递垂体与肾上腺疾病糖尿病

多发性内分泌腺瘤病1型患者垂体瘤的特征及不同突变状态比较

Traits of Patients With Pituitary Tumors in Multiple Endocrine Neoplasia Type 1 and Comparing Different Mutation Status.
PubMed 文献 · J Clin Endocrinol Metab · 2023-01-01

该研究回顾性分析2010至2023年一家三级转诊中心42例多发性内分泌腺瘤病1型(MEN1)患者,其中24例有垂体瘤(PITs),3例侵袭性垂体瘤接受经蝶手术。有垂体瘤者诊断MEN1时中位年龄高于无垂体瘤者;57.1%患者检出MEN1突变,有垂体瘤且携带突变者较无突变者有更多其他MEN1相关肿瘤。

要点

  • 42例MEN1患者中24例有垂体瘤,仅3例为侵袭性并接受经蝶手术。
  • 有垂体瘤者诊断MEN1时中位年龄高于无垂体瘤者。
  • 有垂体瘤者中,携带MEN1突变者较无突变者有更多其他MEN1相关肿瘤。

核心结论

  • 本研究首次比较不同突变状态下MEN1患者伴与不伴垂体瘤的特征。
  • 无MEN1突变的患者器官受累倾向较少,作者认为对其采用较低强度随访可能是合理的。

研究设计与样本

  • 回顾性分析2010至2023年一家三级转诊中心42例MEN1患者的数据。

主要发现

  • 42例MEN1患者中24例有垂体瘤,其中3例为侵袭性并接受经蝶手术。
  • 随访中1例垂体瘤增大。
  • 有垂体瘤者诊断MEN1时中位年龄高于无垂体瘤者。
  • 57.1%患者检出MEN1突变,包括5种新突变。
  • 在有垂体瘤者中,突变阳性组(突变+/垂体瘤+)较突变阴性组(突变-/垂体瘤+)有更多其他MEN1相关肿瘤。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Recent studies suggest that the clinical characteristics and biological behavior of pituitary tumors (PITs) in patients with multiple endocrine neoplasia type 1 (MEN1) may not be as aggressive as previously reported. Increased imaging of the pituitary as recommended by screening guidelines identifies more tumors, potentially at an earlier stage. However, it is unknown if these tumors have different clinical characteristics in different MEN1 mutations. OBJECTIVE: To assess characteristics of patients with MEN1 with and without PITs, and compare among different MEN1 mutations. METHODS: Data of patients with MEN1 in a tertiary referral center from 2010 to 2023 were retrospectively analyzed. RESULTS: Forty-two patients with MEN1 were included. Twenty-four patients had PITs, 3 of which were invasive and managed with transsphenoidal surgery. One PIT enlarged during follow-up. Patients with PITs had a higher median age at MEN1 diagnosis than those without PITs. MEN1 mutations were identified in 57.1% of patients, including 5 novel mutations. In patients with PITs, those with MEN1 mutations (mutation+/PIT+ group) had more additional MEN1-associated tumors than those without (mutation-/PIT+ group). The mutation+/PIT+ group had a higher incidence of adrenal tumors and a lower median age at initial manifestation of MEN1 than the mutation-/PIT+ group. The most common neuroendocrine neoplasm was nonfunctional in the mutation+/PIT+ group and insulin-secreting in the mutation-/PIT+ group. CONCLUSION: This is the first study comparing characteristics of patients with MEN1 with and without PITs harboring different mutations. Patients without MEN1 mutations tended to have less organ involvement and it might be reasonable for them to receive less intensive follow-up.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Lin KY, Kuo YT, Cheng MF, et al. Traits of Patients With Pituitary Tumors in Multiple Endocrine Neoplasia Type 1 and Comparing Different Mutation Status. J Clin Endocrinol Metab. 2023. PMID: 37390813. doi:10.1210/clinem/dgad387

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。